These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2504719

  • 1. Anticoagulant low molecular weight heparin does not enhance the activation of plasminogen by tissue plasminogen activator.
    Andrade-Gordon P, Strickland S.
    J Biol Chem; 1989 Sep 15; 264(26):15177-81. PubMed ID: 2504719
    [Abstract] [Full Text] [Related]

  • 2. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P, Strickland S.
    Biochemistry; 1986 Jul 15; 25(14):4033-40. PubMed ID: 2943315
    [Abstract] [Full Text] [Related]

  • 3. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T, Yamauchi T, Horie M, Nagumo T, Suzuki H.
    Thromb Res; 2000 Sep 15; 99(6):623-34. PubMed ID: 10974349
    [Abstract] [Full Text] [Related]

  • 4. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM, Gamba C, Kordich LC.
    Thromb Res; 2007 Sep 15; 120(5):745-52. PubMed ID: 17270255
    [Abstract] [Full Text] [Related]

  • 5. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE, Smith CJ.
    Arch Biochem Biophys; 1993 Nov 15; 307(1):138-45. PubMed ID: 8239651
    [Abstract] [Full Text] [Related]

  • 6. Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.
    Andrade-Gordon P, Strickland S.
    Proc Natl Acad Sci U S A; 1990 Mar 15; 87(5):1865-9. PubMed ID: 2106684
    [Abstract] [Full Text] [Related]

  • 7. Purification and characterization of a plasma factor which cleaves single-chain form of t-PA and u-PA.
    Okada K, Fukao H, Tanaka H, Ueshima S, Matsuo O.
    Thromb Res Suppl; 1990 Mar 15; 10():27-43. PubMed ID: 2156352
    [Abstract] [Full Text] [Related]

  • 8. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 15; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 9. On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site.
    Keijer J, Linders M, Wegman JJ, Ehrlich HJ, Mertens K, Pannekoek H.
    Blood; 1991 Sep 01; 78(5):1254-61. PubMed ID: 1715220
    [Abstract] [Full Text] [Related]

  • 10. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
    Reuning U, Bang NU.
    Arterioscler Thromb; 1992 Oct 01; 12(10):1161-70. PubMed ID: 1327097
    [Abstract] [Full Text] [Related]

  • 11. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
    Hajjar KA, Hamel NM.
    J Biol Chem; 1990 Feb 15; 265(5):2908-16. PubMed ID: 2154465
    [Abstract] [Full Text] [Related]

  • 12. Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.
    Rijken DC, de Munk GA, Jie AF.
    Thromb Haemost; 1993 Nov 15; 70(5):867-72. PubMed ID: 8128448
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S, McMillan E, Doctor V.
    Blood Coagul Fibrinolysis; 2010 Jul 15; 21(5):425-30. PubMed ID: 20445443
    [Abstract] [Full Text] [Related]

  • 14. Stimulation of plasmin catalyzed conversion of single-chain to two-chain urokinase-type plasminogen activator by sulfated polysaccharides.
    Rydzewski A, Takada Y, Takada A.
    Thromb Haemost; 1989 Sep 29; 62(2):752-5. PubMed ID: 2479114
    [Abstract] [Full Text] [Related]

  • 15. Kinetic studies on the effect of heparin and fibrin on plasminogen activators.
    Fears R.
    Biochem J; 1988 Jan 01; 249(1):77-81. PubMed ID: 2449177
    [Abstract] [Full Text] [Related]

  • 16. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    J Biol Chem; 1988 Dec 15; 263(35):19083-91. PubMed ID: 3143723
    [Abstract] [Full Text] [Related]

  • 17. Marked potentiation of the plasminogenolytic activity of pro-urokinase by unfractionated heparin and a low molecular-weight heparin.
    Dosne AM, Bendetowicz AV, Kher A, Samama M.
    Thromb Res; 1988 Sep 15; 51(6):627-30. PubMed ID: 2847356
    [No Abstract] [Full Text] [Related]

  • 18. Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.
    Gong Y, Kim SO, Felez J, Grella DK, Castellino FJ, Miles LA.
    J Biol Chem; 2001 Jun 01; 276(22):19078-83. PubMed ID: 11264290
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the plasminogen activator activity units of urinary-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA).
    Creighton-Kempsford LJ, Pring JB, Gaffney PJ.
    Blood Coagul Fibrinolysis; 1992 Aug 01; 3(4):481-3. PubMed ID: 1420825
    [Abstract] [Full Text] [Related]

  • 20. Interaction of fucoidan with proteases and inhibitors of coagulation and fibrinolysis.
    Minix R, Doctor VM.
    Thromb Res; 1997 Sep 01; 87(5):419-29. PubMed ID: 9306616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.